Stanford Medicine provides monkeypox test
Stanford Medicine now provides a test for the monkeypox virus. Rapid identification of infected people will help combat the virus’s spread and facilitate patient care.
COVID vaccine approved for young kids
Children as young as 6 months can now receive the Pfizer BioNTech and Moderna mRNA vaccines.
1,000+genes linked to severe COVID-19
Using machine learning, researchers from Stanford Medicine and their collaborators found specific genetic signals in people who develop severe coronavirus infection.
What to know about monkeypox
The monkeypox virus is normally endemic to Africa but has recently been found on other continents. It spreads through prolonged, direct contact with infected people or their bedding, clothing and towels.
COVID RNA lingers in feces
People with mild to moderate COVID-19 can shed viral RNA in their feces months after initial infection, Stanford researchers find. Those who do often have nausea, vomiting and abdominal pain.
Students create low-tech antiviral method
Using household items, Stanford students have developed a way to make affordable nasal drops with the potential to slow the spread of viruses like COVID-19.
Vaccines bolster immunity from prior infection
Two-dose COVID-19 vaccines significantly increase protection against hospitalization and death in people who had the illness before they were immunized.
Test can predict severe dengue
Researchers have created a test that can predict which dengue patients will likely have mild symptoms and which should be clinically monitored for a high risk of severe illness.
The pandemic turns 2
Stanford Medicine scientists explain what we know, and what we don’t know, about living with COVID-19 two years after the World Health Organization declared a pandemic.
Cancer drugs might be used to treat TB
Tuberculosis lesions in the lungs have high levels of proteins that suppress the immune system. Cancer drugs that target these proteins could be used to fight the bacterial infection.
‘Military police’ cells stem autoimmunity
A new study has identified a way that the immune system shoots down its own cells when their anti-viral activity threatens to become friendly fire. The finding could pave the way to new treatments for autoimmune diseases.
- Big Data
- Cardiovascular Health
- Chemical Biology
- Chronic Disease
- Developmental Biology
- Global Health
- Health Policy
- Infectious Disease
- Mental Health
- Patient Care
- Precision Health
- Preventive Medicine
- Stem Cells
- Women's Health